David P. Sonne

2.4k total citations
53 papers, 1.6k citations indexed

About

David P. Sonne is a scholar working on Endocrinology, Diabetes and Metabolism, Surgery and Oncology. According to data from OpenAlex, David P. Sonne has authored 53 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 30 papers in Endocrinology, Diabetes and Metabolism, 21 papers in Surgery and 19 papers in Oncology. Recurrent topics in David P. Sonne's work include Diabetes Treatment and Management (24 papers), Drug Transport and Resistance Mechanisms (17 papers) and Liver Disease Diagnosis and Treatment (10 papers). David P. Sonne is often cited by papers focused on Diabetes Treatment and Management (24 papers), Drug Transport and Resistance Mechanisms (17 papers) and Liver Disease Diagnosis and Treatment (10 papers). David P. Sonne collaborates with scholars based in Denmark, Netherlands and Sweden. David P. Sonne's co-authors include Filip K. Knop, Tina Vilsbøll, Marek Treiman, Thomas Engstrøm, Morten Hansen, Jens J. Holst, Andreas Brønden, F. Samuel van Nierop, Maarten R. Soeters and Bianca Hemmingsen and has published in prestigious journals such as SHILAP Revista de lepidopterología, Gastroenterology and The Journal of Clinical Endocrinology & Metabolism.

In The Last Decade

David P. Sonne

51 papers receiving 1.6k citations

Peers

David P. Sonne
David P. Sonne
Citations per year, relative to David P. Sonne David P. Sonne (= 1×) peers Valdis Pīrāgs

Countries citing papers authored by David P. Sonne

Since Specialization
Citations

This map shows the geographic impact of David P. Sonne's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David P. Sonne with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David P. Sonne more than expected).

Fields of papers citing papers by David P. Sonne

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David P. Sonne. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David P. Sonne. The network helps show where David P. Sonne may publish in the future.

Co-authorship network of co-authors of David P. Sonne

This figure shows the co-authorship network connecting the top 25 collaborators of David P. Sonne. A scholar is included among the top collaborators of David P. Sonne based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David P. Sonne. David P. Sonne is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Thorsen, Steffen Ullitz, et al.. (2025). The Effect of ABCB1 Polymorphisms on the Efficacy of Antidepressants. Basic & Clinical Pharmacology & Toxicology. 137(4). e70097–e70097.
2.
Krych, Łukasz, David P. Sonne, Julie Lyng Forman, et al.. (2024). Liraglutide and Colesevelam Change Serum and Fecal Bile Acid Levels in a Randomized Trial With Patients With Bile Acid Diarrhea. Clinical and Translational Gastroenterology. 15(11). e00772–e00772. 4 indexed citations
3.
Kirketerp‐Møller, Klaus, et al.. (2024). A First-in-Human Randomized Clinical Study Investigating the Safety and Tolerability of Stabilized Hypochlorous Acid in Patients with Chronic Leg Ulcers. Advances in Wound Care. 13(11). 529–541. 1 indexed citations
4.
Kelstrup, Louise, David P. Sonne, Andreas Brønden, et al.. (2024). Increased gallbladder emptying and reduced GLP ‐1 response in pregnancy with and without gestational diabetes mellitus. Diabetes Obesity and Metabolism. 27(2). 697–709. 2 indexed citations
5.
Brønden, Andreas, et al.. (2024). The Body weight Reducing Effects of Tirzepatide in People with and without Type 2 Diabetes: A Review on Efficacy and Adverse Effects. Patient Preference and Adherence. Volume 18. 373–382. 17 indexed citations
6.
Riis, Troels, et al.. (2023). Octreotide improves human lymphatic fluid transport a translational trial. European Journal of Cardio-Thoracic Surgery. 65(1).
7.
Brønden, Andreas, Julie Lyng Forman, Anne Haaber, et al.. (2022). Safety and efficacy of liraglutide versus colesevelam for the treatment of bile acid diarrhoea: a randomised, double-blind, active-comparator, non-inferiority clinical trial. ˜The œLancet. Gastroenterology & hepatology. 7(10). 922–931. 29 indexed citations
8.
Sonne, David P., Jens J. Holst, Jens F. Rehfeld, et al.. (2022). Enterohepatic, Gluco-metabolic, and Gut Microbial Characterization of Individuals With Bile Acid Malabsorption. SHILAP Revista de lepidopterología. 1(3). 299–312. 8 indexed citations
9.
Backer, Vibeke, Ulf Sjöbring, Jesper Sonne, et al.. (2021). A randomized, double-blind, placebo-controlled phase 1 trial of inhaled and intranasal niclosamide: A broad spectrum antiviral candidate for treatment of COVID-19. The Lancet Regional Health - Europe. 4. 100084–100084. 47 indexed citations
10.
Sonne, David P., et al.. (2020). What is on the horizon for type 2 diabetes pharmacotherapy? – An overview of the antidiabetic drug development pipeline. Expert Opinion on Drug Discovery. 15(11). 1253–1265. 10 indexed citations
11.
Brønden, Andreas, et al.. (2019). Remission of Bile Acid Malabsorption Symptoms Following Treatment With the Glucagon-Like Peptide 1 Receptor Agonist Liraglutide. Gastroenterology. 157(2). 569–571. 19 indexed citations
12.
Demant, Mia, Jonatan I. Bagger, Malte P. Suppli, et al.. (2018). Determinants of Fasting Hyperglucagonemia in Patients with Type 2 Diabetes and Nondiabetic Control Subjects. Metabolic Syndrome and Related Disorders. 16(10). 530–536. 21 indexed citations
13.
Sun, Emily, Richard L. Young, Morten Hansen, et al.. (2018). Metformin-induced glucagon-like peptide-1 secretion contributes to the actions of metformin in type 2 diabetes. JCI Insight. 3(23). 130 indexed citations
14.
Sonne, David P., et al.. (2018). [Effects of glucagon-like peptides on gallbladder motility].. PubMed. 180(50). 2 indexed citations
15.
Sonne, David P., F. Samuel van Nierop, Willem Kulik, et al.. (2016). Postprandial Plasma Concentrations of Individual Bile Acids and FGF-19 in Patients With Type 2 Diabetes. The Journal of Clinical Endocrinology & Metabolism. 101(8). 3002–3009. 111 indexed citations
16.
Rohde, Ulrich, David P. Sonne, Mikkel Christensen, et al.. (2016). Cholecystokinin-Induced Gallbladder Emptying and Metformin Elicit Additive Glucagon-Like Peptide-1 Responses. The Journal of Clinical Endocrinology & Metabolism. 101(5). 2076–2083. 30 indexed citations
17.
Nierop, F. Samuel van, Matthijs J. Scheltema, Hannah M. Eggink, et al.. (2016). Clinical relevance of the bile acid receptor TGR5 in metabolism. The Lancet Diabetes & Endocrinology. 5(3). 224–233. 122 indexed citations
18.
Hansen, Morten, David P. Sonne, & Filip K. Knop. (2014). Bile Acid Sequestrants: Glucose-Lowering Mechanisms and Efficacy in Type 2 Diabetes. Current Diabetes Reports. 14(5). 482–482. 44 indexed citations
19.
Sonne, David P., Jens F. Rehfeld, Jens J. Holst, Tina Vilsbøll, & Filip K. Knop. (2014). Postprandial gallbladder emptying in patients with type 2 diabetes: potential implications for bile-induced secretion of glucagon-like peptide 1. European Journal of Endocrinology. 171(4). 407–419. 53 indexed citations
20.
Sonne, David P., Morten Hansen, & Filip K. Knop. (2014). MECHANISMS IN ENDOCRINOLOGY: Bile acid sequestrants in type 2 diabetes: potential effects on GLP1 secretion. European Journal of Endocrinology. 171(2). R47–R65. 59 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026